Related Experiment Video

Updated: Jul 29, 2025

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.1K

Sparcl1 and Atherosclerosis

Xu Cheng1,2, Xinyan Chen2,3, Min Zhang3

  • 1Department of Cardiovascular Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, People's Republic of China.

Journal of Inflammation Research
|May 23, 2023
PubMed

Insights

Sparc-like protein 1 (Sparcl-1) may play a role in atherosclerosis, a condition linked to endothelial dysfunction and cancer. Further research is recommended to explore Sparcl-1

Area of Science:

  • Cardiovascular Science
  • Oncology
  • Molecular Biology

Background:

  • Atherosclerosis involves endothelial cell damage, adhesion, and proliferation.
  • Atherosclerosis and cancer share common pathophysiological processes.
  • Sparc-like protein 1 (Sparcl-1) is implicated in tumor development but its cardiovascular role is understudied.

Purpose of the Study:

  • To investigate the potential link between Sparcl-1 and atherosclerosis.
  • To highlight the role of Sparcl-1 in endothelial dysfunction and blood vessel integrity.
  • To provide recommendations for future research on Sparcl-1 in atherogenesis.

Main Methods:

  • Literature review of studies on Sparcl-1, atherosclerosis, and cancer.
  • Analysis of Sparcl-1's known functions in cell adhesion, migration, and proliferation.
  • Examination of Sparcl-1's relationship with blood vessel integrity.

Main Results:

  • Sparcl-1 is an extracellular matrix protein with potential oncogenic properties.
  • Sparcl-1 influences cell adhesion, migration, and proliferation, processes relevant to atherogenesis.
  • Existing research on Sparcl-1's cardiovascular implications is limited.

Conclusions:

  • Sparcl-1's role in atherosclerosis warrants further investigation.
  • Understanding Sparcl-1's function could offer new insights into cardiovascular disease mechanisms.
  • Future studies should focus on Sparcl-1's specific contributions to atherogenesis.
Keywords:
Sparcl-1atherogenesiscancer

More Related Videos

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

13.8K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.2K

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
14
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
18
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
29
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
34